Zacks.com featured highlights NVIDIA, AppLovin and Insulet

For Immediate ReleaseChicago, IL – February 3, 2025 – Stocks in this week’s article are NVIDIA Corp. NVDA, AppLovin Corp. APP and Insulet Corp. PODD.NVIDIA & 2 Other Profitable Stocks to Buy in FebruaryFebruary has traditionally been a less-than-bullish month for stocks. However, things have improved since the 1990s, with stocks ending in the green more frequently in February.Thus, investors can benefit from the possible upward trajectory by focusing on profitable stocks over unprofitable ones and using fundamental accounting ratios as the key indicators of performance. We have selected the most successful and commonly used profitability ratio to evaluate a company’s performance.To that end, NVIDIA Corp., AppLovin Corp. and Insulet Corp. have been selected as the top picks with a high net income ratio.Net Income RatioThe net income ratio shows a company’s profitability level. It reflects the percentage of net income to total sales revenues. Using the net income ratio, one can determine a firm’s effectiveness in meeting operating and non-operating expenses from revenues. A higher net income ratio usually implies a company’s ability to generate ample revenues and successfully manage all business functions.Here are three of the 32 stocks that qualified for the screening:NVIDIA NVIDIA Corporation leads in visual computing technologies and invented the graphic processing unit or GPU. The 12-month net profit margin of NVDA is 55.7%.The company’s expected earnings growth rate for the current year is 126.2%. NVIDIA currently has a Zacks Rank #2 (read more: Buy NVIDIA Stock, DeepSeek's Threat is Exaggerated).AppLovin AppLovin creates a software platform for advertisers to boost marketing and monetization of their content globally. The 12-month net profit margin of APP is 26.9%.The company’s expected earnings growth rate for the current year is 317.4%. AppLovin currently has a Zacks Rank #1.InsuletInsulet is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The 12-month net profit margin of PODD is 21.2%.The company’s expected earnings growth rate for the current year is 17.1%. Insulet currently has a Zacks Rank #2.You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.Click here to sign up for a free trial to the Research Wizard today.For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2407821/nvidia-2-other-profitable-stocks-to-buy-in-februaryZacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.Contact: Jim GiaquintoCompany: Zacks.comPhone: 312-265-9268Email: pr@zacks.comVisit: https://www.zacks.com/Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report NVIDIA Corporation (NVDA): Free Stock Analysis Report Insulet Corporation (PODD): Free Stock Analysis Report AppLovin Corporation (APP): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks